Dr. Paul D. Wetzel, MD

Dr. Wetzel practices at Endoscopy Center of the Central Coast in San Luis Obispo, California.

Dr. Wetzel's NPI, 1366427221, was assigned on December 13, 2005. Dr. Wetzel graduated from UC Irvine School of Medicine in 1998. Dr. Wetzel holds California license A71477.

Dr. Wetzel's primary practice is Endoscopy Center of the Central Coast, at 77 Casa St Ste 106, San Luis Obispo, CA 93405. The practice phone is (805) 541-1021.

Dr. Wetzel's primary practice is Endoscopy Center of the Central Coast in San Luis Obispo, California. Dr. Wetzel is also affiliated with Dignity Health - French Hospital Medical Center. The medical group on file is San Luis Gastroenterology. Dmand AI also links Dr. Wetzel to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wetzel practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Wetzel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Wetzel is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Wetzel is licensed in California.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Wetzel treats.

CMS data shows 1,204 Medicare services from Dr. Wetzel across 12 procedure codes in 2024, for 775 Medicare patients. Medicare paid $152,297 for them.

CMS counts 775 Medicare patients who saw Dr. Wetzel in 2024. The largest group is 65 to 74, with 435 patients. 71% of them have high cholesterol, and 63% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wetzel's median patient age at 68, with 54% women.

In 2024, Dr. Wetzel wrote 721 Medicare Part D claims for 310 patients. 73% of them were for generic drugs. CMS names the drug for 582 of them, across 16 drugs with 11 or more claims each, at $181,534 in total drug cost. In 2023, CMS named 406 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 20 out of 100 for Dr. Wetzel for performance year 2024, reported individually. Dr. Wetzel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 246 procedures of colonoscopy by Dr. Wetzel, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Wetzel. The most frequent topics are Electric Stimulation Therapy, Electrodes, Implanted and Gastric Emptying.

CMS Open Payments shows 110 general payments to Dr. Wetzel from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,259.

Dr. Wetzel graduated from UC Irvine School of Medicine in 1998.

Dr. Wetzel is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.